Lightchain Capital - aVenture Asset Manager Research
Location
St. Louis, MO, US
Founded
2018
Lightchain Capital is a venture capital firm specializing in early-stage investments in life sciences companies, particularly those focused on improving cancer outcomes. The firm typically participates in Seed and Series A funding rounds, supporting innovative startups with the potential to make significant advancements in cancer treatment and patient care.
Notable portfolio companies include AI Proteins, Nextrna Therapeutics, and SimpleRose, which have collectively raised substantial funding. Lightchain Capital is led by experienced partners with a strong background in life sciences and venture capital. The firm offers unique value-add services such as strategic guidance, regulatory support, and access to a network of industry experts to help portfolio companies navigate the complexities of the healthcare sector.
Lightchain Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
